A research study to know the effect of Resveratrol-Copper in reducing mouth ulcers in patients receiving chemoradiotherapy for locally advanced cancers of throat.
Phase 2
- Conditions
- Health Condition 1: C109- Malignant neoplasm of oropharynx,unspecified
- Registration Number
- CTRI/2019/10/021508
- Lead Sponsor
- Tata Research Administration Council
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Histologically proven treatment naive oropharyngeal squamous cell carcinoma
2. Male or female patients 18 years and above.
3. Patients who have given written informed consent
4. Patients with performance status of 0,1 or 2 (ECOG scale)
5. Stage III/IV oropharyngeal cancers
6. Patients planned for radical chemoradiotherapy
Exclusion Criteria
1. Medical comorbidities like hypertensive, diabetes mellitus, Hepatitis B and HIV positive, etc.
2. Stage I/II oropharyngeal cancers indicated for single modality therapy
3. Patient unable to give informed consent.
4. Patient unsuitable for radical treatment.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method